TriArm Therapeutics Funding: $60M Raised, Series A (2021)
TriArm Therapeutics is based in Shanghai, China. It has raised $60M in total funding. Latest round: Series A.
TriArm Therapeutics funding overview
TriArm Therapeutics is based in Shanghai, China. TriArm Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for TriArm Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Panacea Venture, VI Venture, HT Capital, Efung Capital, LO Co-Investment Fund, 金浦健康基金 and 1 others. 7 distinct backers are named across the disclosed rounds.
TriArm Therapeutics at a glance
Total raised
$60M
Latest round
Series A
Latest round date
September 2021
Headquarters
Shanghai, China
Notable investors
Panacea Venture, VI Venture, HT Capital, Efung Capital, LO Co-Investment Fund, 金浦健康基金, 瑞伏医疗健康基金
Frequently asked about TriArm Therapeutics funding
How much has TriArm Therapeutics raised?
TriArm Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in TriArm Therapeutics?
Panacea Venture, VI Venture, HT Capital, Efung Capital, LO Co-Investment Fund, 金浦健康基金 are named among the investors backing TriArm Therapeutics.
What was the latest TriArm Therapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2021.
Where is TriArm Therapeutics based?
TriArm Therapeutics is based in Shanghai, China.
When did TriArm Therapeutics last raise?
The last disclosed TriArm Therapeutics round closed in September 2021 at Series A.
Round data for TriArm Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
